Last reviewed · How we verify

NCT03491449: TICA

Intensive Treatment of Blood Pressure in Acute Ischemic Stroke. Study TICA 2

Status unknown NA Last updated 9 April 2018
What this trial tests

NA trial testing Group A in Brain Ischemia in 90 participants. Status unknown.

Timeline
13 February 2017
Primary endpoint
13 February 2019
13 February 2020

Quick facts

Lead sponsorManuel Rodríguez
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment90
Start date13 February 2017
Primary completion13 February 2019
Estimated completion13 February 2020
Sites3 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Manuel Rodríguez

Who can join

Adults 18 to 85, any sex, with Brain Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Demonstrate that maintenance of systolic blood pressure between 140 and 160 mm Hg during the acute phase of ischemic stroke is more effective than management according to the International Guideline (treat when systolic blood pressure exceeds 185 mm Hg)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Group A

Trials testing the same drug.

Other recruiting trials for Brain Ischemia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing